iifl-logo

Akums Drugs & Pharmaceuticals Ltd Share Price

530.6
(0.12%)
Apr 25, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open535
  • Day's High543
  • 52 Wk High1,175.9
  • Prev. Close529.95
  • Day's Low510
  • 52 Wk Low 405
  • Turnover (lac)2,812.77
  • P/E108.93
  • Face Value2
  • Book Value80.01
  • EPS4.87
  • Mkt. Cap (Cr.)8,351.33
  • Div. Yield0
View All Historical Data
No Records Found

Akums Drugs & Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

535

Prev. Close

529.95

Turnover(Lac.)

2,812.77

Day's High

543

Day's Low

510

52 Week's High

1,175.9

52 Week's Low

405

Book Value

80.01

Face Value

2

Mkt Cap (₹ Cr.)

8,351.33

P/E

108.93

EPS

4.87

Divi. Yield

0

Akums Drugs & Pharmaceuticals Ltd Corporate Action

1 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Akums Drugs & Pharmaceuticals Ltd NEWS AND UPDATE

Akums Drugs & Pharm a shares close at a 17% premium
6 Aug 2024|03:43 PM

The organisation is the largest CDMO serving the Indian pharmaceutical industry, with a proven track record and a broad clientele.

Read More
Akums Drugs Lists With 6% Premium
6 Aug 2024|09:56 AM

The IPO comprised a fresh issue of shares worth ₹680 crore and an offer-for-sale (OFS) of 1.73 crore shares, aggregating ₹1,177 crore.

Read More
Akums Drugs & Pharma IPO subscribed 43 times so far
1 Aug 2024|03:26 PM

The IPO consists of a fresh issue of ₹680 crore and an offer for sale (OFS) of up to 1.73 crore shares at a face value of ₹2 each.

Read More
Akums Drugs IPO Subscribed 3.20 times so far Day 2
31 Jul 2024|03:48 PM

On Monday, the business said that it had received ₹829 crore from anchor investors ahead of the public share sale subscription period.

Read More
Akums Drugs and Pharmaceuticals IPO subscribed 97%
30 Jul 2024|03:09 PM

The IPO includes a new issue of 1 Crore shares worth ₹680.00 Crore and an offer for sale of 1.73 Crore shares worth ₹1,176.74 Crore.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Akums Drugs & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

26 Apr, 2025|08:51 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 75.26%

Foreign: 0.00%

Indian: 75.26%

Non-Promoter- 13.17%

Institutions: 13.16%

Non-Institutions: 8.84%

Custodian: 2.72%

Share Price

Akums Drugs & Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

28.61

28.61

14.31

1.3

Preference Capital

0

0

0

0

Reserves

115.27

282.89

171.23

565.75

Net Worth

143.88

311.5

185.54

567.05

Minority Interest

View Balance Sheet

No Record Found

View Profit & Loss

No Record Found

View Cash Flow

No Record Found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022

Gross Sales

4,178.18

3,654.82

3,671.89

Excise Duty

0

0

0

Net Sales

4,178.18

3,654.82

3,671.89

Other Operating Income

0

0

0

Other Income

34.03

46.11

22.83

Akums Drugs & Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,787.4

137.434,32,9601,181.050.755,985.3398.33

Divis Laboratories Ltd

DIVISLAB

6,012.5

79.591,65,003.325940.482,297513.62

Cipla Ltd

CIPLA

1,525.9

26.921,25,285.641,438.150.844,134.87360.73

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,238.9

61.671,12,502.674850.842,330222.38

Mankind Pharma Ltd

MANKIND

2,557.5

55.531,07,385.94416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Akums Drugs & Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Managing Director

SANDEEP JAIN

Managing Director

SANJEEV JAIN

Independent Director

Matangi Gowrishankar

Company Sec. & Compli. Officer

Dharamvir Malik

Independent Director

Kewal Kundanlal Handa

Independent Director

NAND LAL KALRA

Whole-time Director

Sanjay Sinha

Non Executive Director

SUNIL KUMAR THAKUR

Independent Director

SATWINDER SINGH

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Akums Drugs & Pharmaceuticals Ltd

Summary

Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC.Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. They are into sale of branded pharmaceutical formulations and manufacturing of Active Pharmaceutical Ingredients. Some of the other services include formulation research and development, preparation and filing of regulatory dossiers into the Indian and global markets, and other testing services. Some of manufacturing units have been accredited by various global regulatory agencies such as the European Good Manufacturing Practice, the World Health Organization Good Manufacturing Practice and the United States National Sanitation Foundation. Their specialization extends to development and sale of APIs across diverse chemical processes and therapeutic areas such as anti-infective, respiratory and diabetes. In 2004, the Company established first plant for oral dosage commissioned at 19, 20, 21, Sector 6A, Haridwar, Uttarakhand. In 2007, it established dedicated manufacturing site for oral liquid dosage and sterile products both at Haridwar, Uttarakhand. It incorporated Maxcure Nutravedics Limited to venture into nutraceuticals in 2009. In 2010, it dedicated a facility for hormones ; de
Read More

Company FAQs

What is the Akums Drugs & Pharmaceuticals Ltd share price today?

The Akums Drugs & Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹530.6 today.

What is the Market Cap of Akums Drugs & Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Akums Drugs & Pharmaceuticals Ltd is ₹8351.33 Cr. as of 25 Apr ‘25

What is the PE and PB ratio of Akums Drugs & Pharmaceuticals Ltd?

The PE and PB ratios of Akums Drugs & Pharmaceuticals Ltd is 108.93 and 3.73 as of 25 Apr ‘25

What is the 52 Week High and Low of Akums Drugs & Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Akums Drugs & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Akums Drugs & Pharmaceuticals Ltd is ₹405 and ₹1175.9 as of 25 Apr ‘25

What is the CAGR of Akums Drugs & Pharmaceuticals Ltd?

Akums Drugs & Pharmaceuticals Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at -33.44%, 6 Month at -39.46%, 3 Month at -6.67% and 1 Month at 7.92%.

What is the shareholding pattern of Akums Drugs & Pharmaceuticals Ltd?

The shareholding pattern of Akums Drugs & Pharmaceuticals Ltd is as follows:
Promoters - 75.26 %
Institutions - 13.16 %
Public - 8.85 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.